|
1
|
Kopp HG, Krauss K, Fehm T, Staebler A,
Zahm J, Vogel W, Kanz L and Mayer F: Symptomatic bone marrow
involvement in breast cancer-clinical presentation, treatment, and
prognosis: A single institution review of 22 cases. Anticancer Res.
31:4025–4030. 2011.PubMed/NCBI
|
|
2
|
Kourie HR, Antoun J, El Rassy E, Rassy M,
Sader-Ghorra C and Kattan J: Osteonecrosis of the jaw during
biyearly treatment with zoledronic acid for aromatase inhibitor
associated bone loss in early breast cancer: A literature review. J
Bone Oncol. 4:77–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang L, Garcia-Manero G, Jabbour E,
Goswami M, Routbort MJ, Medeiros LJ, Jorgensen JL and Wang SA:
Persistence of immunophenotypically aberrant CD34+
myeloid progenitors is frequent in bone marrow of patients with
myelodysplastic syndromes and myelodysplastic/myeloproliferative
neoplasms treated with hypomethylating agents. J Clin Pathol. Apr
15–2016.(Epub ahead of print). View Article : Google Scholar
|
|
4
|
Sever C, Abbott CL, de Baca ME, Khoury JD,
Perkins SL, Reichard KK, Taylor A, Terebelo HR, Colasacco C, Rumble
RB and Thomas NE: Bone marrow synoptic reporting for hematologic
neoplasms: Guideline from the college of american pathologists
pathology and laboratory quality center. Arch Pathol Lab Med.
140:932–949. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dell'Amore A, Asadi N, Caroli G, Dolci G,
Bini A and Stella F: Recurrent primary cardiac osteosarcoma: A case
report and literature review. Gen Thorac Cardiovasc Surg.
62:175–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farcas N, Arzi B and Verstraete FJ: Oral
and maxillofacial osteosarcoma in dogs: A review. Vet Comp Oncol.
12:169–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang C, Li X, Zhao H and Liu H: Long
non-coding RNAs: Potential new biomarkers for predicting tumor
invasion and metastasis. Mol Cancer. 15:622016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiong XD, Ren X, Cai MY, Yang JW, Liu X
and Yang JM: Long non-coding RNAs: An emerging powerhouse in the
battle between life and death of tumor cells. Drug Resist Updat.
26:28–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reiche K, Kasack K, Schreiber S, Lüders T,
Due EU, Naume B, Riis M, Kristensen VN, Horn F, Børresen-Dale AL,
et al: Long non-coding RNAs differentially expressed between normal
versus primary breast tumor tissues disclose converse changes to
breast cancer-related protein-coding genes. PLoS One.
9:e1060762014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu M, Sun W, Liu Y and Dong X: The role
of lncRNA MALAT1 in bone metastasis in patients with non-small cell
lung cancer. Oncol Rep. 36:1679–1685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Z, Wang R, Zhang T and Dong X:
Hypoxia/lncRNA-AK123072/EGFR pathway induced metastasis and
invasion in gastric cancer. Int J Clin Exp Med. 8:19954–19968.
2015.PubMed/NCBI
|
|
12
|
Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F
and Liu L: Long non-coding RNA PTENP1 functions as a ceRNA to
modulate PTEN level by decoying miR-106b and miR-93 in gastric
cancer. Oncotarget. 8:26079–26089. 2017.PubMed/NCBI
|
|
13
|
Poliseno L, Haimovic A, Christos PJ, Vega
Y, de Miera Saenz EC, Shapiro R, Pavlick A, Berman RS, Darvishian F
and Osman I: Deletion of PTENP1 pseudogene in human melanoma. J
Invest Dermatol. 131:2497–2500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC,
Hwang SM and Hu YC: Suppression of hepatocellular carcinoma by
baculovirus-mediated expression of long non-coding RNA PTENP1 and
MicroRNA regulation. Biomaterials. 44:71–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma J, Sawai H, Ochi N, Matsuo Y, Xu D,
Yasuda A, Takahashi H, Wakasugi T and Takeyama H: PTEN regulates
angiogenesis through PI3K/Akt/VEGF signaling pathway in human
pancreatic cancer cells. Mol Cell Biochem. 331:161–171. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Akca H, Demiray A, Aslan M, Acikbas I and
Tokgun O: Tumour suppressor PTEN enhanced enzyme activity of GPx,
SOD and catalase by suppression of PI3K/AKT pathway in non-small
cell lung cancer cell lines. J Enzyme Inhib Med Chem. 28:539–544.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang B, Su Y, Yang Q, Lv D, Zhang W, Tang
K, Wang H, Zhang R and Liu Y: Overexpression of long non-coding RNA
HOTAIR promotes tumor growth and metastasis in human osteosarcoma.
Mol Cells. 38:432–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo X, Meng Y, Sheng X, Guan Y, Zhang F,
Han Z, Kang Y, Tai G, Zhou Y and Cheng H: Tunicamycin enhances
human colon cancer cells to TRAIL-induced apoptosis by
JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR
pathway. Anticancer Drugs. 28:66–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Woo SM, Min KJ and Kwon TK:
Melatonin-mediated Bim up-regulation and cyclooxygenase-2 (COX-2)
down-regulation enhances tunicamycin-induced apoptosis in
MDA-MB-231 cells. J Pineal Res. 58:310–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim EJ, Heo J and Kim YH: Tunicamycin
promotes apoptosis in leukemia cells through ROS generation and
downregulation of survivin expression. Apoptosis. 20:1087–1098.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bai FL, Yu YH, Tian H, Ren GP, Wang H,
Zhou B, Han XH, Yu QZ and Li DS: Genetically engineered Newcastle
disease virus expressing interleukin-2 and TNF-related
apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther.
15:1226–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandez-Pol S, Ma L, Ohgami RS and Arber
DA: Immunohistochemistry for p53 is a useful tool to identify cases
of acute myeloid leukemia with myelodysplasia-related changes that
are TP53 mutated, have complex karyotype, and have poor prognosis.
Mod Pathol. 30:382–392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ellis BC, Molloy PL and Graham LD: CRNDE:
A long non-coding rna involved in cancer, neurobiology, and
development. Front Genet. 3:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakurai K, Reon BJ, Anaya J and Dutta A:
The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive
nexus. Mol Cancer Res. 13:828–838. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo X, Deng L, Deng K, Wang H, Shan T,
Zhou H, Liang Z, Xia J and Li C: Pseudogene PTENP1 suppresses
gastric cancer progression by modulating PTEN. Anticancer Agents
Med Chem. 16:456–464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kovalenko TF, Sorokina AV, Ozolinia LA and
Patrushev LI: Pseudogene PTENP1 5′-region methylation in
endometrial cancer and hyperplasias. Bioorg Khim. 39:445–453.
2013.(In Russian). PubMed/NCBI
|
|
31
|
Wang L, Zhang N, Wang Z, Ai DM, Cao ZY and
Pan HP: Pseudogene PTENP1 Functions as a competing endogenous RNA
(ceRNA) to regulate PTEN expression by sponging miR-499-5p.
Biochemistry (Mosc). 81:739–747. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li
H, Lin H, Huang W and Qian H: Pro-apoptotic cationic host defense
peptides rich in lysine or arginine to reverse drug resistance by
disrupting tumor cell membrane. Amino acids. Jun 29–2017.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chung SK, Lee MG, Ryu BK, Lee JH, Han J,
Byun DS, Chae KS, Lee KY, Jang JY, Kim HJ and Chi SG: Frequent
alteration of XAF1 in human colorectal cancers: Implication for
tumor cell resistance to apoptotic stresses. Gastroenterology.
132:2459–2477. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Özgür E, Mert U, Isin M, Okutan M, Dalay N
and Gezer U: Differential expression of long non-coding RNAs during
genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clin
Exp Med. 13:119–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu Q, Lv T, Wu Y, Shi X, Liu H and Song
Y: Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour
proliferation and promotes apoptosis in Non-small cell lung cancer.
J Cell Mol Med. 21:2184–2198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu T, Wu D, Wu Q, Zou B, Huang X, Cheng X,
Wu Y, Hong K, Li P, Yang R, et al: Knockdown of long non-coding
RNA-ZFAS1 protects cardiomyocytes against acute myocardial
infarction via anti-apoptosis by regulating miR-150/CRP. J Cell
Biochem. 118:3281–3289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Y, Shen Z, Yan Y, Wang B, Zhang J,
Shen C, Li T, Ye C, Gao Z, Peng G, et al: Long non-coding RNA GAS5
inhibits cell proliferation, induces G0/G1 arrest and apoptosis,
and functions as a prognostic marker in colorectal cancer. Oncol
Lett. 13:3151–3158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao YH, Ji TF, Luo Q and Yu JL: Long
non-coding RNA H19 induces hippocampal neuronal apoptosis via Wnt
signaling in a streptozotocin-induced rat model of diabetes
mellitus. Oncotarget. 8:64827–64839. 2017.PubMed/NCBI
|
|
39
|
Jaffe N: Osteosarcoma: Review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Iwata S, Yonemoto T, Iizasa T, Niibe Y,
Kamoda H and Ishii T: Oligo-recurrence of osteosarcoma patients:
Treatment strategies for pulmonary metastases. Ann Surg Oncol. 22
Suppl 3:S1332–S1338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
42
|
Senerchia AA, Macedo CR, Ferman S,
Scopinaro M, Cacciavillano W, Boldrini E, de Moraes Lins VL, Rey G,
de Oliveira CT, Castillo L, et al: Results of a randomized,
prospective clinical trial evaluating metronomic chemotherapy in
nonmetastatic patients with high-grade, operable osteosarcomas of
the extremities: A report from the Latin American Group of
Osteosarcoma Treatment. Cancer. 123:1003–1010. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cui H, Wu S, Shang Y, Li Z, Chen M, Li F
and Wang C: Pleurotus nebrodensis polysaccharide(PN50G) evokes A549
cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress
tumor growth. Food Funct. 7:1616–1627. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang T, Yang SD, Liu S, Wang H, Liu H and
Ding WY: 17β-estradiol inhibites tumor necrosis factor-α induced
apoptosis of human nucleus pulposus cells via the PI3K/Akt pathway.
Med Sci Monit. 22:4312–4322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhuo B, Li Y, Li Z, Qin H, Sun Q, Zhang F,
Shen Y, Shi Y and Wang R: PI3K/Akt signaling mediated Hexokinase-2
expression inhibits cell apoptosis and promotes tumor growth in
pediatric osteosarcoma. Biochem Biophys Res Commun. 464:401–406.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu GL, Yang HJ, Liu B and Liu T: Effects
of microrna-19b on the proliferation, apoptosis, and migration of
wilms' tumor cells via the PTEN/PI3K/AKT signaling pathway. J Cell
Biochem. 118:3424–3434. 2017. View Article : Google Scholar : PubMed/NCBI
|
